Ying Luo is the founder of Cullgen. Cullgen has raised $121M in total funding. Latest round: Series B. Based in San Diego, United States.
Ying Luo, Ph.D., is the Chair and President of Cullgen, a biotechnology company co-founded by him in 2018. Cullgen focuses on developing targeted protein degraders for diseases lacking effective therapies. The company has secured significant funding and, in December 2023, announced a reverse merger with Pulmatrix to become publicly listed.
Full founder directory · Investor directory · Company funding database · Fundraising library